Mark Wahlberg, the A-list actor known for roles in films such as “Boogie Nights” and the upcoming thriller “By Any Means,” will appear on the main stage at TechCrunch Disrupt 2026. He is scheduled to sit down with Bruce K. Lee, founder and CEO of Keebeck Wealth Management, for a conversation focused on Wahlberg’s evolution as an entrepreneur rather than his acting career.
Over the past two decades, Wahlberg has expanded well beyond entertainment, establishing a production company, a restaurant chain, apparel and fitness brands, and a significant portfolio of angel investments. He also founded the Mark Wahlberg Youth Foundation 25 years ago to support inner-city youth. During the session, he plans to share insights on how he has applied his cultural intelligence to navigate sophisticated business and finance environments.
Wahlberg, who has previously relied on instinct regarding people, culture, and markets, is now working with Lee to develop more disciplined, institutional-level investing strategies, with a particular emphasis on healthcare and wellness startups. The discussion will address common pitfalls faced by high-profile entertainers and athletes, how Wahlberg leverages his career trust for deal flow, and the technologies currently capturing his interest.
TechCrunch Disrupt 2026 takes place from October 13-15 at Moscone West in San Francisco, hosting over 10,000 tech leaders across 200 sessions. Attendees can purchase tickets now, with prices set to increase on September 25.
I love that he’s leveraging cultural intelligence for business. That’s a skill most traditional investors ignore. Gonna grab a ticket to hear him out.
Funny seeing a movie star on stage with a wealth management CEO. Hope the conversation isn’t just fluff and actual actionable advice is shared.
The shift from instinct-driven deals to disciplined strategies is a huge lesson. Would love to hear the specifics on his healthcare picks.
Mark’s foundation work is genuinely impressive. I hope he talks about how his philanthropy influences his investment thesis in healthcare.
Can an actor really bring substantive insights to institutional investing, or is this just another celebrity endorsement play for the conference?